Literature DB >> 12426663

Hypersensitivity vasculitis and cytokines.

Selim Nalbant1, Bayram Koc, Cihan Top, Yasar Kucukardali, Yavuz Baykal, Mehmet Danaci, Ismail Hakki Kocer.   

Abstract

OBJECTIVE: Hypersensitivity vasculitis (HSV) is secondary vasculitis due to an immune response to exogenous substances. Because of the relative rarity of the vasculitides there are no reports on the role cytokines. This report evaluates some of cytokines which might be involved in pathophysiological events of HSV.
MATERIAL AND METHODS: Patients with HSV ( n=20) were classified as active ( n=12) ornd inactive ( n=8) according to a vasculitis activity index for systemic necrotizing vasculitis (VAI). All the patients were males. A control group was formed from 20 healthy male employees of our department. We performed tests for serum interleukins 6, IL-10, sIL-2 receptor, tumor necrosis factor (TNF) alpha, C-reactive protein (CRP) levels using enzyme-linked immunosorbent assay and erythrocyte sedimentation rate (ESR).
RESULTS: The mean ESR value, CRP, and fibrinogen levels were significantly different in both active and inactive HSV from those in the healthy group; they were also significantly higher in the active than in the inactive group. There was no significant difference between healthy and inactive groups for serum IL-10, IL-6, sIL-2 receptor, and TNFalpha levels. However, it was also significantly higher for in active HSV patients than in the healthy group. Similar results were obtained comparing active and inactive groups, namely, all cytokine levels were significantly higher for all patients. The most striking finding is the high correlation of ESR (also for CRP, fibrinogen) with serum levels of TNFalpha and IL-10, but not with IL-6 and IL2R.
CONCLUSIONS: These data show that serum TNFalpha and IL-10 levels can be studied in comparison to traditional markers of inflammation such as sedimentation rate or C-reactive protein. This may lead to new approaches to treating or managing HSV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426663     DOI: 10.1007/s00296-002-0235-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  6 in total

1.  Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway.

Authors:  Y-H Yang; Y-H Huang; Y-L Lin; L-C Wang; Y-H Chuang; H-H Yu; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Incidence of autoimmune diseases in patients with scabies: a nationwide population-based study in Taiwan.

Authors:  Jui-Ming Liu; Feng-Hsiang Chiu; Chien-Yu Lin; Fung-Wei Chang; Ren-Jun Hsu
Journal:  Rheumatol Int       Date:  2017-04-18       Impact factor: 2.631

3.  Role of interleukin-6 in immune complex induced models of vascular injury.

Authors:  Shannon D McClintock; Adam G Barron; Eric W Olle; Michael P Deogracias; Roscoe L Warner; Mark Opp; Kent J Johnson
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

4.  The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura.

Authors:  Yao-Hsu Yang; Huey-Jen Lai; Cheng-Kai Kao; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2004-07-15       Impact factor: 3.714

5.  Dermatologic comorbidities of the patients with severe COVID-19: A case-control study.

Authors:  Ömer Kutlu; Neslihan Demirel Öğüt; Ece Erbağcı; Ahmet Metin
Journal:  Dermatol Ther       Date:  2021-01-10       Impact factor: 3.858

6.  Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report.

Authors:  A Mayor-Ibarguren; M Feito-Rodriguez; L Quintana Castanedo; E Ruiz-Bravo; D Montero Vega; P Herranz-Pinto
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-03       Impact factor: 9.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.